Big Picture Bio
Big Picture Bio develops predictive models to identify synergistic drug combinations, with a focus on cancer therapies designed to prevent or overcome treatment resistance.
Big Picture Bio has raised €2.6M across 1 funding round from 5 investors, most recently a Pre-Seed round in Sep 2026. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKbigpicturebio.com ↗
Total raised
€2.6M
€2,561,714
Funding rounds
1
Investors
5
distinct backers
Active since
2026-09
latest 2026-09
Funding by year
EUR raised per year · 2026 YTDBig Picture Bio — funding by year — interactive chart.
Data table
| Big Picture Bio — funding by year | |
|---|---|
| 2026 | €2.6M |
Signals
High confidenceRaise-next likelihood10
base rate 24% for Pre-Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-18 | Pre-Seed | €2.6M | Exceptional Ventures,Gloucester Ventures,Innovate UK’s Investor Partnerships Programme,John White,Kadmos Capital | View deal → |